Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Clene inc crawled time : 12:03 save search
Clene Nanomedicine Awarded Michael J. Fox Foundation Grant to Accelerate the Development of CNM-Au8 as a Treatment for Parkinson’s Disease
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
CLNN S | $0.3492 5.85% 5.53% 1.2M
|
|
| O: 2.41%
H: 6.27%
C: 3.27%
disease treatment cnm-au8 parkinson
Clene Nanomedicine to Present Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021
Published: 2021-02-19 (Crawled : 12:03) - globenewswire.com
CLNN S | $0.3492 5.85% 5.53% 1.2M
|
|
| O: 0.36%
H: 3.15%
C: -2.44%
multiple sclerosis phase 2 sclerosis
Clene Nanomedicine Initiates Phase 2 Study of CNM-ZnAg for Patients with COVID-19
Published: 2021-02-16 (Crawled : 12:03) - globenewswire.com
CLNN S | $0.3492 5.85% 5.53% 1.2M
|
|
| O: 0.56%
H: 31.37%
C: 29.78%
covid phase 2 covid-19
Clene Nanomedicine Receives Patent Notice of Allowance in the United States for using Gold Nanocrystals for the Treatment of Multiple Sclerosis
Published: 2021-01-19 (Crawled : 12:03) - globenewswire.com
CLNN S | $0.3492 5.85% 5.53% 1.2M
|
|
| O: 4.51%
H: 0.0%
C: -2.16%
multiple sclerosis sclerosis patent treatment
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.